Claritin Dosing for Pediatric Patients
For children aged 2-5 years, give Claritin (loratadine) 5 mg once daily; for children 6 years and older, give 10 mg once daily.
Age-Specific Dosing Recommendations
Children 2-5 Years
- Dose: 5 mg once daily (available as syrup/liquid formulation)
- Maximum: Do not exceed one dose in 24 hours
- This dosing is supported by both FDA labeling 1 and clinical practice guidelines 2
Children 6 Years and Older
- Dose: 10 mg once daily (tablet or syrup)
- Maximum: Not more than 1 tablet/dose in 24 hours
- Same adult dose applies 1
Children Under 2 Years
- Consult a physician before use - the FDA label specifically directs caregivers to ask a doctor for this age group 1
Important Clinical Context
Loratadine has an excellent safety profile in young children, distinguishing it from first-generation antihistamines. The 2008 rhinitis practice parameter specifically notes that second-generation antihistamines including loratadine "have been shown to be well tolerated and to have a very good safety profile" in young children 3. This is particularly relevant given the FDA's concerns about OTC cough and cold medications in children under 6 years, which do not apply to second-generation antihistamines like loratadine.
Pharmacokinetic Support
Research demonstrates that 5 mg loratadine in children aged 2-5 years provides exposure similar to the 10 mg adult dose, validating the weight-adjusted dosing approach 4. The drug was well tolerated with no clinically meaningful adverse events in this age group.
Special Populations
For children with liver or kidney disease: Consult a physician before dosing, as clearance may be impaired 1.
Common Pitfalls to Avoid
- Do not use multiple antihistamine products simultaneously - this increases overdose risk without additional benefit
- Do not confuse with desloratadine (Clarinex) - desloratadine has different pediatric dosing: 1.25 mg daily for ages 2-5 years and 2.5 mg daily for ages 6-11 years 2
- Avoid first-generation antihistamines when loratadine is appropriate - they carry higher sedation risk and have not demonstrated superior efficacy in children
Formulation Considerations
Loratadine syrup (1 mg/mL) is the preferred formulation for children 2-5 years to ensure accurate dosing and ease of administration 4. Tablets are appropriate for children 6 years and older who can safely swallow them.